|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, March 02, 2017 ) Browse 181 market data tables and 44 figures spread through 225 pages and in-depth TOC on “Immunohistochemistry Market”
http://www.marketsandmarkets.com/Market-Reports/immunohistochemistry-market-121632939.html
Early buyers will receive 10% customization on this report.
Growing prevalence of cancer and rapidly increasing geriatric population across the globe are the major factors driving the growth of the immunohistochemistry market. Other important factors driving market growth include increasing healthcare spending and improving healthcare infrastructure resulting in an increase in the number of hospitals and diagnostic laboratories.
The growing consolidation, incorporation of nanotechnology in immunohistochemistry, adoption of multiplex arrays, and automation in this market are the key trends in the market. Rapid growth in the developing countries across APAC and Latin America and the increasing demand for personalized medicine offer significant growth opportunities for players in the immunohistochemistry market.
Speak To Our Research Analysts:
http://www.marketsandmarkets.com/speaktoanalyst.asp?id=121632939
In this report, the immunohistochemistry market is segmented based on product, application, end user, and region. This report also discusses the key market drivers, restraints, opportunities, and challenges for this market and its submarkets.
In 2015, the hospitals and diagnostic laboratories segment accounted for the largest share of immunohistochemistry market, by end user. The large share of the hospitals and diagnostic laboratories segment can be attributed to growing use of immunohistochemistry reagents, antibodies, and equipment for diagnostic procedures. Furthermore, technological advancements such as automated sample preparation and digital pathology and its greater utilization in the diagnosis of many chronic and life-threatening diseases are expected to contribute to the growth of this market.
In 2015, the immunohistochemistry antibody segment accounted for the largest share of immunohistochemistry market, by product. The large share of the immunohistochemistry antibody segment can be attributed to improved approval rate for therapeutic antibodies by regulatory authorities, increasing adoption of targeted immunotherapy, and increased R&D expenditure of pharmaceutical and biotechnology companies.
Read More | Get the Sample Pages:
http://www.marketsandmarkets.com/requestsample.asp?id=121632939
The increasing risk of infectious diseases and rising demand for immune-therapeutics are expected to further drive market growth for this segment. Moreover, the rising adoption of immunohistochemistry test, high-throughput assays, such as array comparative genomic hybridization, cDNA microarray, next-generation sequencing techniques, and histological tests, have led to the rapid discovery of thousands of potential antibodies.
In 2015, the cancer segment accounted for the largest share of the immunohistochemistry market, by application. The large share of diagnostic application in cancer diseases can be attributed to increasing prevalence of cancer, rapidly increasing geriatric population in developed countries, increased awareness and demand for immunohistochemistry in histopathology, and demand for early diagnosis in developing countries in Asia-Pacific and Latin America.
The major players in the immunohistochemistry market are F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Merck Millipore (U.S.), Bio-Rad Laboratories, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Abcam plc (U.K.), Cell Signaling Technology, Inc. (U.S.), and Bio SB Inc. (U.S.).
About MarketsandMarkets:
MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Rohan
MarketsandMarkets
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Telephone No : 1-888-600-6441
MarketsandMarkets
Mr. Rohan
1-888-600-6441
sales@marketsandmarkets.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
